Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Eicosanoids are crucial for skin health, and targeting their pathways may help treat skin conditions.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

PCOS often leads to sleep problems, especially obstructive sleep apnea, affecting overall health.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

Some skin diseases and their treatments can negatively affect male fertility.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Natural products may help treat skin inflammation from abnormal adrenal hormones.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Nourkrin® with Marilex® may significantly increase hair growth and alopecia could be an early sign of metabolic syndrome.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Diagnosing and treating PCOS in teenagers is difficult, and the focus is on lifestyle changes and medication to improve health and prevent future issues.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

PCOS affects many women and requires early detection and symptom management.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Obesity and bariatric surgery can cause hair thinning and temporary hair loss due to nutritional deficiencies and stress.